본문 바로가기

전체 글

(819)
Down Syndrome Market Analysis & Forecast to 2030 Down Syndrome (DS) is a genetic disorder caused by the presence of an extra copy of chromosome 21, making a total of 47 chromosomes instead of 46. Some of the common conditions associated with Down Syndrome include intellectual disability, a characteristic facial appearance, and weak muscle tone (hypotonia) in infancy. People affected with Down Syndrome may have a variety of congenital disabilit..
Atopic Dermatitis Market Analysis and Market Forecast 2030 Atopic dermatitis (AD), also known as atopic eczema, is a type of inflammation of the skin (dermatitis). It results in itchy, red, swollen, and cracked skin. Clear fluid may come from the affected areas, which often thickens over time. While the condition may occur at any age, it typically starts in childhood with changing severity over the years. In children under one year of age, much of the b..
Dubai’s Pharmaceutical Market According to estimates, Dubai’s pharma market is projected to grow by 9.6 per cent to USD 25.6 billion (AED 94 billion) by 2022, depicting a profitable opportunity to the pharma companies worldwide. Dubai’s growing population, technological advancements and central geographical location are sure to lend a helping hand in increasing the value of the GCC and MEA pharmaceutical markets in the upcom..
Existing and Emerging healthcare Innovations E-Health (Telehealth & Telemedicine), Wearable biosensors, Artificial intelligence (AI), Point-of-care testing, and Augmented Reality are some of the innovations that have significantly transformed the healthcare industry. Drone-delivered medical supplies system, Internet of Things (IoT), the stem-cell cure for diabetes, Precision Medicine, Regenerative medicine, a more diverse and accurate glob..
Soft Tissue Sarcoma Epidemiology In the year 2017, the total Soft tissue sarcoma incident population in the 7MM was observed to be approximately 40,155. The US accounted for the maximum number of soft tissue sarcoma incidence cases, followed by Germany. The Key Soft tissue sarcoma companies working in the field including Eli Lilly and Company, Novartis, GSK, Bayer Pharmaceuticals, Blueprint Medicines, Advenchen Laboratories, LL..
Soft tissue sarcoma treatment market Soft tissue sarcoma — a rare tumor — affecting less than 1% of the population — has the major unmet need in the form of limited treatment options for patients. Cytotoxic chemotherapy has been the mainstay of #therapy for decades. Pharma companies including Blueprint Medicines, Advenchen Laboratories, LLC / Jiangsu Chia-Tai Tianqing Pharmaceutical, Karyopharm Therapeutics Inc., Deciphera Pharmace..
Gene therapy might make cocaine less addictive According to the “National Survey on Drug Use and Health”, around 2.2 million Americans falling in the age group of 12 or older, were found to be actively using cocaine in the year 2017. The last few years have witnessed a substantial investment in R&D aimed at finding effective Medication for cocaine addiction. Gene therapy can be a potential and a novel approach to treat cocaine addiction and ..
Opioid Withdrawal Syndrome Pipeline The Opioid withdrawal syndrome market is going to leap forward attributed to the enhancement and strengthening of weak clinical Opioid withdrawal syndrome pipeline. Key Pharma players such as Chiesi Farmaceutici, BioXcel Therapeutics, Aphios Pharmaceutical and others are going to advance the Opioid Withdrawal Syndrome therapy market further in future. To read more on Opioid withdrawal syndrome p..